Answers are grounded in this paper and cite their sources.
SUMMARY Hypertonic saline (HS) solutions are increasingly used for reduction of elevated intracranial pressure in head‐injured children and adults. Advantages over other hypertonic solutions such as mannitol were demonstrated in experimental and clinical studies with respect to intracranial pressure reduction, improvement of cerebral perfusion pressure, and cerebral oxygenation. However, there remains considerable uncertainty about the indications for the use of HS, the appropriate administration protocol, and the potential risks of using HS. The rationale of this article is to bring a systematic order into the currently available results and to help develop a protocol for the indication and application of HS solutions in adults and children with severe brain injury. Furthermore, fields of necessary future research are outlined.
No takes yet. Share an insight, caveat, or question.
Berger et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: